Influence of 1-year treatment period on responses to anticholinergic inhalation in patients with chronic obstructive pulmonary disease

Current Therapeutic Research - Clinical and Experimental

Volumn 58, Issue 2, 1997, Pages 78-87

  Teramoto, Shinji ^a   Matsuse, Takeshi ^a   Ouchi, Yasuyoshi ^a   Fukuchi, Yoshinosuke ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

anticholinergic drug; bronchodilator response; chronic obstructive pulmonary disease; exercise capacity; exercise testing

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXITROPIUM BROMIDE;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SPIROMETRY;

EID: 0031000166     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(97)80116-6     Document Type: Article

References (36)

1. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. NEJM. 1987;317: 1309-1314.
2. Rennard SI. Combination bronchodilator therapy in COPD. Chest. 1995;107(Suppl): 171S-175S.
3. Donohue JF. Management of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1995;1:129-134.
4. Furguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. NEJM. 1993;320:1017-1022.
5. Petty TL. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 856-day multicenter study. Chest. 1994;105:1411-1419.
6. Koyama H, Nishimura K, Ikeda A, Izumi T. A comparison of the bronchodilator effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease. Chest. 1993;104:1743-1747.
7. Braun SR, McKenzie WN, Copeland C, et al. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med. 1989;149:544-547.
8. Gross NJ. Anticholinergic agents in chronic bronchitis and emphysema. Postgrad Med J. 1987;63(Suppl 1):S29-S34.
9. Tashkin DP, Ashutosh K, Bleecker ER, et al. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study. Am J Med. 1986;81(Suppl 5A):81-90.
10. Gross NJ. Ipratropium bromide. NEJM. 1988;319:486-494.
11. Gross NJ, Skorodin MS. Role of the parasympathetic system in airway obstruction due to emphysema. NEJM. 1984;311:421-425.
12. Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effect of ipratropium bromide and metaproterenol sulfate in acute exacerbation of COPD. Chest. 1990;98:835-839.
13. Karpel JP. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest. 1991;99:871-876.
14. 2-agonist and combination therapy on respiratory impedance in COPD. Chest. 1992; 101:166-173.
15. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 1992;5: 659-664.
16. Spence DPS, Hay JG, Carter J, et al. Oxygen denaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: Effect of oxitropium bromide. Thorax. 1993;48:1145-1150.
17. Ikeda A, Nishimura K, Koyama H, et al. Oxitropium bromide improves exercise performance in patients with COPD. Chest. 1994;106:1740-1745.
18. Koyama H, Nishimura K, Ikeda A, Izumi T. Bronchial responsiveness and acute bronchodilating response in chronic obstructive pulmonary disease and diffuse panbronchitis. Thorax. 1994;49:540-544.
19. Teramoto S, Fukichi Y. Improvements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease. Age Ageing. 1995;24:278-282.
20. Teramoto S, Fukuchi Y, Orimo H. Effects on inhaled anticholinergic drug on dyspnea and gas exchange during exercise in chronic obstructive pulmonary disease. Chest. 1993;103: 1774-1782.
21. Teramoto S, Fukuchi Y. The reduced sensation of dyspnea during exercise by inhaled oxitropium bromide in severe COPD patients. Chest. 1995;108:1479-1480. Letter.
22. Wiggins J. The role of anticholinergics in 'stable' chronic obstructive pulmonary disease: Unanswered questions. Respiration. 1994;61:303-304.
23. Baldwin E de F, Cournand A, Richards DW. Pulmonary insufficiency: I. Physiologic classification, clinical methods of analysis. Standard values in normal subjects. Medicine. 1948;27:243-278.
24. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of single-breath pulmonary diffusing capacity test. Am Rev Respir Dis. 1961;84:789-806.
25. Teramoto S, Fukuchi Y, Nagase T, et al. A comparison of ventilation components between young and elderly men during exercise. J Gerontol (Biol Sci). 1995;50A:B34-B39.
26. Teramoto S, Fukuchi Y, Nagase T, et al. Quantitative assessment of dyspnea during exercise before and after bullectomy in giant bulla. Chest. 1992;102:1362-1366.
27. Ziment I. The β-agonist controversy: Impact in COPD. Chest. 1995;107(Suppl):198S-205S.
28. Morley J, Sanjar S, Newth C. Viewpoint: Untoward effects of beta-adrenoreceptor agonists in asthma. Eur Respir J. 1990;3:228-233.
29. Anthoniesen NR, Wright EC. IPPB trial group. Response to inhaled bronchodilators in COPD. Chest. 1987;91(Suppl 5):36S-39S.
30. Van Schayck CP, Dompeling E, Van Heerwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomized controlled study. BMJ. 1991;303:1426-1431.
31. Kersjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease. NEJM. 1992;327:1413-1419.
32. 1: The Lung Health Study. JAMA. 1994;272:1497-1505.
33. 2-agonist in improving dyspnea and exercise limitation in COPD? Chest. 1995;108: 730-735.
34. Brown SE, Prager RS, Shinto RA, et al. Cardiopulmonary response to exercise in chronic airflow obstruction. Effects of inhaled atropine sulfate. Chest. 1986;89:7-11.
35. Leitch AG, Hokin JM, Ellis DA, et al. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax. 1978;33:711-713.
36. Teramoto S. Chronic lung disease and the perception of breathlessness: Clinical perspective. Eur Respir J. 1995;8:338. Letter.